Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01545596 · ClinicalTrials.gov registry record · NA
Will a Real Time Advisory for Double Low State Change Clinical Behavior and Impact Outcomes
A NA study of Ability to Influence Behavior and Information Systems, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 20,237
- Enrollment target
- 1
- Study location
NCT01545596 is a NA study of Ability to Influence Behavior and Information Systems that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 20,237 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01545596, a NA study of Ability to Influence Behavior and Information Systems, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 20,237 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to use a decision-support system combined with an electronic anesthesia record to detect double low clinical conditions (Mean Arterial Pressure (MAP) \< 75 mmHg, and Bispectral Index (BIS) \< 45) and generate alerts suggesting hemodynamic support. Specifically, the project will test the hypothesis that providing Double Low alerts reduces 90-day mortality. Secondary outcomes will be the fraction of alerts that generate early clinician responses, subsequent changes in MAP and hospital length of stay.
Conditions Studied
Interventions
- BEHAVIORAL Notification Group
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,237 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01545596
The ClinicalTrials.gov registry entry for NCT01545596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20,237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ability to Influence Behavior appearing as the primary indexed condition, and to 1 intervention - of which Notification Group is the first listed.
NCT01545596 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01545596 about?
NCT01545596 is a clinical study titled "Will a Real Time Advisory for Double Low State Change Clinical Behavior and Impact Outcomes". The objective of this study is to use a decision-support system combined with an electronic anesthesia record to detect double low clinical conditions (Mean Arterial Pressure (MAP) \< 75 mmHg, and Bispectral Index (BIS) \< 45) and generate alerts suggesting hemodynamic support. Specifically, the pro...
What is the current status of trial NCT01545596?
This trial is currently completed. It is a NA study. The enrollment target is 20,237 participants. The study started on 2011-01. Estimated completion is 2014-05.
What conditions does trial NCT01545596 study?
This clinical trial studies the following conditions: Ability to Influence Behavior, Information Systems.
What interventions are being tested in trial NCT01545596?
The interventions under investigation include: Notification Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01545596?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01545596 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.